Cargando…
Modulation of angiogenesis with siRNA inhibitors for novel therapeutics
Cancer and many other serious diseases are characterized by the uncontrolled growth of new blood vessels. Recently, RNA interference (RNAi) has reinvigorated the therapeutic prospects for inhibiting gene expression and promises many advantages over binding inhibitors, including high specificity, whi...
Autores principales: | Lu, Patrick Y., Xie, Frank Y., Woodle, Martin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185626/ https://www.ncbi.nlm.nih.gov/pubmed/15760768 http://dx.doi.org/10.1016/j.molmed.2005.01.005 |
Ejemplares similares
-
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
por: Xie, Frank Y., et al.
Publicado: (2006) -
Targeted Delivery of siRNA Therapeutics to Malignant Tumors
por: Leng, Qixin, et al.
Publicado: (2017) -
Application of siRNA Against SARS in the Rhesus Macaque Model
por: Tang, Qingquan, et al.
Publicado: (2008) -
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque
por: Li, Bao-jian, et al.
Publicado: (2005) -
Delivering Small Interfering RNA for Novel Therapeutics
por: Lu, Patrick Y., et al.
Publicado: (2008)